Top Markets
Coin of the day
Molecure S.A. Molecure S.A.

Molecure S.A.

MOC
株式のランク #26168
Operating as a biopharmaceutical firm in Poland, Molecure S.A. specializes in... Operating as a biopharmaceutical firm in Poland, Molecure S.A. specializes in the research, development, and commercialization of innovative therapies designed to combat neoplastic (cancer) and inflammatory conditions. The company's pipeline prominently features OATD-01, a chitotriosidase/acidic mammalian chitinase inhibitor that has successfully advanced through Phase I clinical trials for the treatment of idiopathic pulmonary fibrosis and sarcoidosis. Additionally, Molecure is progressing its YKL-40 program for cancer and fibrosis, OATD-02 for oncology applications, and a Deubiquitinase program. Established in 2012, this Warsaw-headquartered enterprise adopted the name Molecure S.A. in March 2022, having previously been known as OncoArendi Therapeutics S.A.
株価
$1.73
時価総額
$42.88M
変化(1日)
2.16%
変化(1年)
-18.85%
PL
取引 Molecure S.A. (MOC)

カテゴリー

Molecure S.A.(MOC)の配当利回りの履歴
Molecure S.A.(銘柄コード: MOC)の配当利回り(TTM)は2026時点で0です。
過去5年間の平均配当利回り: 0.00%
Molecure S.A.(MOC)の2026から2026までの配当利回りの履歴
各年末時点の配当利回り(TTM)
配当利回り 変化
提供された日付のデータは十分ではありません。
類似企業または競合他社の配当利回り(TTM)